Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms Of Orbitofrontal Stimulation in Depression (MOOD)

NCT07230990 is registered in ClinicalTrials.gov with Subha Subramanian as lead sponsor.

NCT NCT07230990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07230990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms Of Orbitofrontal Stimulation in Depression (MOOD)
Lead sponsor
Subha Subramanian
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2026
Completion date
December 31, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)